Overview

Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature Ejaculation

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether PED-1 (15mg) and PED-2 (30mg) are tolerable and effective in the treatment of premature ejaculation.
Phase:
Phase 2
Details
Lead Sponsor:
Symyoo
Treatments:
Clomipramine